Market Place
Sourcing Support
All News #Library
Bion Pharma’s Generics Dapagliflozin Receives Approval in US
06 Apr 2026 //
FDA
Biocon’s Generics Cabozantinib Receives Tentative Approval in US
17 Mar 2026 //
FDA
Biocon’s Generics Liraglutide Receives Approval in US
11 Mar 2026 //
FDA
Biocon Pharma’s Generics Liraglutide Receives Approval in US
24 Feb 2026 //
FDA
Biocon Pharma’s Generics Everolimus Receives Approval in US
09 Jan 2026 //
FDA
Bion’s Generics Carbidopa Receives Tentative Approval in US
04 Dec 2025 //
FDA
Biocon’s Generics Tofacitinib Receives Tentative Approval in US
17 Nov 2025 //
FDA
Biocon`s Generics Rivaroxaban Receives Approval in US
14 May 2025 //
FDA
Biocon`s Generics Dasatinib Receive Tentative Approval in US
17 Jan 2025 //
FDA
Biocon`s Generics Sacubitril; Valsartan Receives Approval in US
30 Aug 2024 //
FDA
Biocon`s Generics Daptomycin Receives Approval in US
29 Aug 2024 //
FDA
Biocon`s Generics Lenalidomide Receives Tentative Approval in US
02 Aug 2024 //
FDA
Biocon`s Generic Lenalidomide Receives Receives Approval in the U.S.
04 May 2023 //
FDA
Biocon Generic Lenalidomide Receives Approval in the U.S
04 May 2023 //
FDA
Biocon` Generic Teriflunomide Receives Approval in the U.S.
13 Mar 2023 //
FDA
Biocon`s Generic Atorvastatin Calcium Receives Approval in the U.S.
23 Nov 2022 //
FDA
Biocon Pharma`s Generic Posaconazole Receives Approval in the U.S.
04 Feb 2022 //
FDA
Biocon Pharma`s Generic Mycophenolic Acid gets Approval in the U.S.
29 Nov 2021 //
FDA
Biocon Pharma Generic Mycophenolic Acid Receives Approval in US
26 Nov 2021 //
FDA
Biocon Pharma Generic Tacrolimus Receives Approval in US
12 Nov 2020 //
FDA
Biocon`s Generic Fingolimod Hydrochloride Receives Approval In Us
11 Dec 2019 //
FDA
Biocon`s Generic Fingolimod Receives Tentative Approval In Us
28 Apr 2017 //
FDA APPROVALS
Biocon`s Insulin Glargine Approved in Mexico For Diabetes
10 Apr 2015 //
BIOCON
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.